Alcoholic liver disease: Update on the role of dietary fat

Biomolecules

Volumn 6, Issue 1, 2016, Pages 2-17

  Kirpich, Irina A ^a   Miller, Matthew E ^a   Cave, Matthew C ^a,b   Joshi Barve, Swati ^a   McClain, Craig J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver disease; Gut microbiota; Oxidized dietary lipids; Oxidized linoleic acid metabolites; Saturated and unsaturated dietary fat

Indexed keywords

ACYL COENZYME A DESATURASE; ALANINE AMINOTRANSFERASE; ANANDAMIDE; ARGININOSUCCINATE SYNTHASE; CORIOLIC ACID; CYTOCHROME P450 2E1; DOCOSAHEXAENOIC ACID; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LINOLEIC ACID; LINOLENIC ACID; LIPOXIN A; LIPOXIN B; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TOLL LIKE RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNSATURATED FATTY ACID; VANILLOID RECEPTOR 1; ALCOHOL; EDIBLE OIL; FAT INTAKE;

ALCOHOL LIVER DISEASE; DOSE RESPONSE; ENDOTOXEMIA; FAT INTAKE; FATTY LIVER; HUMAN; INTESTINE FLORA; LIPID PEROXIDATION; LIPID STORAGE; LIVER FIBROSIS; LIVER NECROSIS; METABOLOME; MORTALITY RATE; MRNA EXPRESSION ASSAY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; LIVER DISEASES, ALCOHOLIC; METABOLISM;

ANIMALS; DIETARY FATS; DIETARY FATS, UNSATURATED; ETHANOL; GASTROINTESTINAL MICROBIOME; HUMANS; LIVER DISEASES, ALCOHOLIC;

EID: 85012108854     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom6010001     Document Type: Review

References (99)

1. Rehm, J.; Samokhvalov, A.; Shield, K. Global burden of alcoholic liver disease. J. Hepatol. 2013, 59, 160-168. [CrossRef] [PubMed]
2. D’Amico, G.; Garcia-Tsao, G.; Pagliaro, L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J. Hepatol. 2006, 44, 217-231. [CrossRef] [PubMed]
3. Wakim-Fleming, J.; Mullen, K.D. Long-term management of alcoholic liver disease. Clin. Liver Dis. 2005, 9, 135-149. [CrossRef] [PubMed]
4. Nanji, A.A. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004, 34, 21-25. [CrossRef] [PubMed]
5. Kirpich, I.A.; Feng, W.; Wang, Y.; Liu, Y.; Barker, D.F.; Barve, S.S.; McClain, C.J. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol. Clin. Exp. Res. 2012, 36, 835-846. [CrossRef] [PubMed]
6. Ronis, M.J.; Korourian, S.; Zipperman, M.; Hakkak, R.; Badger, T.M. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J. Nutr. 2004, 134, 904-912. [PubMed]
7. Zhong, W.; Li, Q.; Xie, G.; Sun, X.; Tan, X.; Sun, X.; Jia, W.; Zhou, Z. Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, G919-G932. [CrossRef] [PubMed]
8. Chen, P.; Torralba, M.; Tan, J.; Embree, M.; Zengler, K.; Stärkel, P.; van Pijkeren, J.P.; DePew, J.; Loomba, R.; Ho, S.B.; et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology 2015, 148, 203-214. CrossRef] [PubMed]
9. You, M.; Considine, R.V.; Leone, T.C.; Kelly, D.P.; Crabb, D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005, 42, 568-577. [CrossRef] [PubMed]
10. Mezey, E. Dietary fat and alcoholic liver disease. Hepatology 1998, 28, 901-905. [CrossRef] [PubMed]
11. Nanji, A.A.; French, S.W. Dietary factors and alcoholic cirrhosis. Alcohol. Clin. Exp. Res. 1986, 10, 271-273. [CrossRef] [PubMed]
12. Lieber, C.S.; Lefèvre, A.; Spritz, N.; Feinman, L.; DeCarli, L.M. Difference in hepatic metabolism of long- and medium-chain fatty acids: The role of fatty acid chain length in the production of the alcoholic fatty liver. J. Clin. Investig. 1967, 46, 1451-1460. [CrossRef] [PubMed]
13. Ronis, M.J.; Baumgardner, J.N.; Sharma, N.; Vantrease, J.; Ferguson, M.; Tong, Y.; Wu, X.; Cleves, M.A.; Badger, T.M. Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med. 2013, 238, 151-162. [CrossRef] [PubMed]
14. Nanji, A.A.; Mendenhall, C.L.; French, S.W. Beef fat prevents alcoholic liver disease in the rat. Alcohol. Clin. Exp. Res. 1989, 13, 15-19. [CrossRef] [PubMed]
15. Nanji, A.A.; Griniuviene, B.; Sadrzadeh, S.M.; Levitsky, S.; McCully, J.D. Effect of type of dietary fat and ethanol on antioxidant enzyme mRNA induction in rat liver. J. Lipid Res. 1995, 36, 736-744. [PubMed]
16. Nanji, A.A.; French, S.W. Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci. 1989, 44, 223-227. [CrossRef]
17. Nanji, A.A.; Zhao, S.; Sadrzadeh, S.M.; Dannenberg, A.J.; Tahan, S.R.; Waxman, D.J. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol. Clin. Exp. Res. 1994, 18, 1280-1285. [CrossRef] [PubMed]
18. Nanji, A.A.; Jokelainen, K.; Tipoe, G.L.; Rahemtulla, A.; Dannenberg, A.J. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J. Pharmacol. Exp. Ther. 2001, 299, 638-644. [PubMed]
19. Kasdallah-Grissa, A.; Nakbi, A.; Koubaa, N.; El-Fazaâ, S.; Gharbi, N.; Kamoun, A.; Hammami, M. Dietary virgin olive oil protects against lipid peroxidation and improves antioxidant status in the liver of rats chronically exposed to ethanol. Nutr. Res. 2008, 28, 472-479. [CrossRef] [PubMed]
20. Chen, Y.L.; Peng, H.C.; Wang, X.D.; Yang, S.C. Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats. Hepatobiliary Surg. Nutr. 2015, 4, 172-183. PubMed]
21. Kirpich, I.A.; Feng, W.; Wang, Y.; Liu, Y.; Beier, J.I.; Arteel, G.E.; Falkner, K.C.; Barve, S.S.; McClain, C.J. Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol. Alcohol 2013, 47, 257-264. [CrossRef] [PubMed]
22. Institute of Shortening and Edible Oils, Inc. Food Fats and Oils. Available online: http://www.iseo.org/httpdocs/Publications/FoodFatsOils2006.pdf (accessed on 5 May 2015).
23. Dubois, V.; Breton, S.; Linder, M.; Fanni, J.; Parmentier, M. Fatty acid profiles of 80 vegetable oils with regard to their nutritional potential. Eur. J. Lipid Sci. Technol. 2007, 109, 710-732. [CrossRef]
24. Nanji, A.A.; Zhao, S.; Lamb, R.G.; Dannenberg, A.J.; Sadrzadeh, S.M.; Waxman, D.J. Changes in cytochromes P-450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: Relationship to dietary fats and pathologic liver injury. Alcohol. Clin. Exp. Res. 1994, 18, 902-908. [CrossRef] [PubMed]
25. Polavarapu, R.; Spitz, D.R.; Sim, J.E.; Follansbee, M.H.; Oberley, L.W.; Rahemtulla, A.; Nanji, A.A. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998, 27, 1317-1323. [CrossRef] [PubMed]
26. Kono, H.; Enomoto, N.; Connor, H.D.; Wheeler, M.D.; Bradford, B.U.; Rivera, C.A.; Kadiiska, M.B.; Mason, R.P.; Thurman, R.G. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278, G467-G476. [PubMed]
27. You, M.; Cao, Q.; Liang, X.; Ajmo, J.M.; Ness, G.C. Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice. J. Nutr. 2008, 138, 497-501. [PubMed]
28. You, M.; Rogers, C.Q. Adiponectin: A key adipokine in alcoholic fatty liver. Exp. Biol. Med. 2009, 234, 850-859. [CrossRef] [PubMed]
29. Li, Q.; Zhong, W.; Qiu, Y.; Kang, X.; Sun, X.; Tan, X.; Zhao, Y.; Sun, X.; Jia, W.; Zhou, Z. Preservation of hepatocyte nuclear factor-4alpha contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcohol. Clin. Exp. Res. 2013, 37, 587-598. [CrossRef] [PubMed]
30. Zhong, W.; Zhao, Y.; McClain, C.J.; Kang, Y.J.; Zhou, Z. Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced downregulation of intestinal tight junction proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299, G643-G651. [CrossRef] [PubMed]
31. Yashodhara, B.M.; Umakanth, S.; Pappachan, J.M.; Bhat, S.K.; Kamath, R.; Choo, B.H. Omega-3 fatty acids: A comprehensive review of their role in health and disease. Postgrad. Med. J. 2009, 85, 84-90. [CrossRef] [PubMed]
32. Lorente-Cebrian, S.; Costa, A.G.; Navas-Carretero, S.; Zabala, M.; Martínez, J.A.; Moreno-Aliaga, M.J. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: A review of the evidence. J. Physiol. Biochem. 2013, 69, 633-651. [CrossRef] [PubMed]
33. Martinez-Fernandez, L.; Laiglesia, L.M.; Huerta, A.E.; Martínez, J.A.; Moreno-Aliaga, M.J. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Prostaglandins Other Lipid Mediat. 2015. [CrossRef] [PubMed]
34. Scorletti, E.; Byrne, C.D. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu. Rev. Nutr. 2013, 33, 231-248. [CrossRef] [PubMed]
35. Ellulu, M.S.; Khaza’ai, H.; Abed, Y.; Rahmat, A.; Ismail, P.; Ranneh, Y. Role of fish oil in human health and possible mechanism to reduce the inflammation. Inflammopharmacology 2015, 23, 79-89. [CrossRef] [PubMed]
36. Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93, 950-962. [CrossRef] [PubMed]
37. Zelber-Sagi, S.; Nitzan-Kaluski, D.; Goldsmith, R.; Webb, M.; Blendis, L.; Halpern, Z.; Oren, R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J. Hepatol. 2007, 47, 711-717. [CrossRef] [PubMed]
38. Russo, G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol. 2009, 77, 937-946. [CrossRef] [PubMed]
39. Spahis, S.; Alvarez, F.; Dubois, J.; Ahmed, N.; Peretti, N.; Levy, E. Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. Prostaglandins Leukot. Essent. Fatty Acids 2015, 99, 25-34. [CrossRef] [PubMed]
40. Capanni, M.; Calella, F.; Biagini, M.R.; Genise, S.; Raimondi, L.; Bedogni, G.; Svegliati-Baroni, G.; Sofi, F.; Milani, S.; Abbate, R.; et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study. Aliment. Pharmacol. Ther. 2006, 23, 1143-1151. [CrossRef] [PubMed]
41. Nobili, V.; Alisi, A.; Della Corte, C.; Risé, P.; Galli, C.; Agostoni, C.; Bedogni, G. Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 1066-1070. [CrossRef] [PubMed]
42. Pachikian, B.D.; Essaghir, A.; Demoulin, J.B.; Neyrinck, A.M.; Catry, E.; de Backer, F.C.; Dejeans, N.; Dewulf, E.M.; Sohet, F.M.; Portois, L.; et al. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: Genomic analysis of cellular targets. PLoS ONE 2011, 6, e23365. [CrossRef] [PubMed]
43. Valenzuela, R.; Espinosa, A.; González-Mañán, D.; D’Espessailles, A.; Fernández, V.; Videla, L.A.; Tapia, G. N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis. PLoS ONE 2012, 7, e46400. [CrossRef] [PubMed]
44. Kajikawa, S.; Harada, T.; Kawashima, A.; Imada, K.; Mizuguchi, K. Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats. Dig. Dis. Sci. 2010, 55, 631-641. [CrossRef] [PubMed]
45. Kajikawa, S.; Harada, T.; Kawashima, A.; Imada, K.; Mizuguchi, K. Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80, 229-238. [CrossRef] [PubMed]
46. Tapia, G.; Valenzuela, R.; Espinosa, A.; Romanque, P.; Dossi, C.; Gonzalez-Mañán, D.; Videla, L.A.; D’Espessailles, A. N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-alpha upregulation and NF-kappaB DNA binding abrogation. Mol. Nutr. Food Res. 2014, 58, 1333-1341. [CrossRef] [PubMed]
47. Dossi, C.G.; Tapia, G.S.; Espinosa, A.; Videla, L.A.; D’Espessailles, A. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: Role of PPAR-alpha and SREBP-1c. J. Nutr. Biochem. 2014, 25, 977-984. [CrossRef] [PubMed]
48. Morimoto, M.; Zern, M.A.; Hagbjörk, A.L.; Ingelman-Sundberg, M.; French, S.W. Fish oil, alcohol, and liver pathology: Role of cytochrome P450 2E1. Proc. Soc. Exp. Biol. Med. 1994, 207, 197-205. [CrossRef] [PubMed]
49. Wada, S.; Yamazaki, T.; Kawano, Y.; Miura, S.; Ezaki, O. Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice. J. Hepatol. 2008, 49, 441-450. [CrossRef] [PubMed]
50. Song, B.J.; Moon, K.H.; Olsson, N.U.; Salem, N., Jr. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 2008, 49, 262-273. [CrossRef] [PubMed]
51. Huang, L.L.; Wan, J.B.; Wang, B.; He, C.W.; Ma, H.; Li, T.W.; Kang, J.X. Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88, 347-353. [CrossRef] [PubMed]
52. Pawlosky, R.J.; Flynn, B.M.; Salem, N.. The effects of low dietary levels of polyunsaturates on alcohol-induced liver disease in rhesus monkeys. Hepatology 1997, 26, 1386-1392. [CrossRef] [PubMed]
53. Pawlosky, R.J.; Salem, N.. Development of alcoholic fatty liver and fibrosis in rhesus monkeys fed a low n-3 fatty acid diet. Alcohol. Clin. Exp. Res. 2004, 28, 1569-1576. [CrossRef] [PubMed]
54. Turner, R.; McLean, C.H.; Silvers, K.M. Are the health benefits of fish oils limited by products of oxidation? Nutr. Res. Rev. 2006, 19, 53-62. [CrossRef] [PubMed]
55. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids; The National Academy Press: Washington, DC, USA, 2005.
56. Kris-Etherton, P.M.; Taylor, D.S.; Yu-Poth, S.; Huth, P.; Moriarty, K.; Fishell, V.; Hargrove, R.L.; Zhao, G.; Etherton, T.D. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 2000, 71, 179S-188S. [PubMed]
57. Choe, E.; Min, D.B. Chemistry of deep-fat frying oils. J. Food Sci. 2007, 72, R77-R86. [CrossRef] [PubMed]
58. Alexander, J.C. Chemical and biological properties related to toxicity of heated fats. J. Toxicol. Environ. Health 1981, 7, 125-138. [CrossRef] [PubMed]
59. Halvorsen, B.L.; Blomhoff, R. Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements. Food Nutr. Res. 2011. [CrossRef] [PubMed]
60. Perez-Herrera, A.; Rangel-Zuñiga, O.A.; Delgado-Lista, J.; Marin, C.; Perez-Martinez, P.; Tasset, I.; Tunez, I.; Quintana-Navarro, G.M.; Lopez-Segura, F.; Luque de Castro, M.D.; et al. The antioxidants in oils heated at frying temperature, whether natural or added, could protect against postprandial oxidative stress in obese people. Food Chem. 2013, 138, 2250-2259. [CrossRef] [PubMed]
61. Kanner, J. Dietary advanced lipid oxidation endproducts are risk factors to human health. Mol. Nutr. Food Res. 2007, 51, 1094-1101. [CrossRef] [PubMed]
62. Ng, C.Y.; Leong, X.F.; Masbah, N.; Adam, S.K.; Kamisah, Y.; Jaarin, K. Heated vegetable oils and cardiovascular disease risk factors. Vasc. Pharmacol. 2014, 61, 1-9. [CrossRef] [PubMed]
63. Perez-Herrera, A.; Delgado-Lista, J.; Torres-Sanchez, L.A.; Rangel-Zuñiga, O.A.; Camargo, A.; Moreno-Navarrete, J.M.; Garcia-Olid, B.; Quintana-Navarro, G.M.; Alcala-Diaz, J.F.; Muñoz-Lopez, C.; et al. The postprandial inflammatory response after ingestion of heated oils in obese persons is reduced by the presence of phenol compounds. Mol. Nutr. Food Res. 2012, 56, 510-514. [CrossRef] [PubMed]
64. Owu, D.U.; Osim, E.E.; Ebong, P.E. Serum liver enzymes profile ofWistar rats following chronic consumption of fresh or oxidized palm oil diets. Acta Trop. 1998, 69, 65-73. [CrossRef]
65. Nwanguma, B.C.; Achebe, A.C.; Ezeanyika, L.U.; Eze, L.C. Toxicity of oxidized fats II: Tissue levels of lipid peroxides in rats fed a thermally oxidized corn oil diet. Food Chem. Toxicol. 1999, 37, 413-416. [CrossRef]
66. Shibayama, Y. Hepatotoxicity of heated and oxygenated corn oil. Exp. Toxicol. Pathol. 1992, 44, 255-258. [CrossRef]
67. Varma, P.S.; Aruna, K.; Rukkumani, R.; Menon, V.P. Alcohol and thermally oxidized pufa induced oxidative stress: Role of N-acetyl cysteine. Ital. J. Biochem. 2004, 53, 10-15. [PubMed]
68. Aruna, K.; Rukkumani, R.; Varma, P.S.; Menon, V.P. Therapeutic role of Cuminum cyminum on ethanol and thermally oxidized sunflower oil induced toxicity. Phytother. Res. 2005, 19, 416-421. [CrossRef] [PubMed]
69. Rukkumani, R.; Aruna, K.; Varma, P.S.; Viswanathan, P.; Rajasekaran, K.N.; Menon, V.P. Protective role of a novel curcuminoid on alcohol and PUFA-induced hyperlipidemia. Toxicol. Mech. Methods 2005, 15, 227-234. [CrossRef] [PubMed]
70. Rukkumani, R.; Aruna, K.; Varma, P.S.; Menon, V.P. Influence of ferulic acid on circulatory prooxidant-antioxidant status during alcohol and PUFA induced toxicity. J. Physiol. Pharmacol. 2004, 55, 551-561. [PubMed]
71. Latha, P.; Chaitanya, D.; Rukkumani, R. Protective effect of Phyllanthus niruri on alcohol and heated sunflower oil induced hyperlipidemia in Wistar rats. Toxicol. Mech. Methods 2010, 20, 498-503. [CrossRef] [PubMed]
72. Ringseis, R.; Muschick, A.; Eder, K. Dietary oxidized fat prevents ethanol-induced triacylglycerol accumulation and increases expression of PPARalpha target genes in rat liver. J. Nutr. 2007, 137, 77-83. [PubMed]
73. Feldstein, A.E.; Lopez, R.; Tamimi, T.A.; Yerian, L.; Chung, Y.M.; Berk, M.; Zhang, R.; McIntyre, T.M.; Hazen, S.L. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 2010, 51, 3046-3054. [CrossRef] [PubMed]
74. Zein, C.O.; Yerian, L.M.; Gogate, P.; Lopez, R.; Kirwan, J.P.; Feldstein, A.E.; McCullough, A.J. Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial. Hepatology 2011, 54, 1610-1619. [CrossRef] [PubMed]
75. Raszeja-Wyszomirska, J.; Safranow, K.; Milkiewicz, M.; Milkiewicz, P.; Szynkowska, A.; Stachowska, E. Lipidic last breath of life in patients with alcoholic liver disease. Prostaglandins Other Lipid Mediat. 2012, 99, 51-56. [CrossRef] [PubMed]
76. Yang, L.; Latchoumycandane, C.; McMullen, M.R.; Pratt, B.T.; Zhang, R.; Papouchado, B.G.; Nagy, L.E.; Feldstein, A.E.; McIntyre, T.M. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. J. Biol. Chem. 2010, 285, 22211-22220. [CrossRef] [PubMed]
77. Liu, H.; Beier, J.I.; Arteel, G.E.; Ramsden, C.E.; Feldstein, A.E.; McClain, C.J.; Kirpich, I.A. Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease. Am. J. Pathol. 2015, 185, 43-54. [CrossRef] [PubMed]
78. Patwardhan, A.M.; Akopian, A.N.; Ruparel, N.B.; Diogenes, A.; Weintraub, S.T.; Uhlson, C.; Murphy, R.C.; Hargreaves, K.M. Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J. Clin. Investig. 2010, 120, 1617-1626. [CrossRef] [PubMed]
79. Patwardhan, A.M.; Scotland, P.E.; Akopian, A.N.; Hargreaves, K.M. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA 2009, 106, 18820-18824. [CrossRef] [PubMed]
80. Whitman, W.B.; Coleman, D.C.; Wiebe, W.J. Prokaryotes: The unseen majority. Proc. Natl. Acad. Sci. USA 1998, 95, 6578-6583. [CrossRef] [PubMed]
81. Tremaroli, V.; Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489, 242-249. [CrossRef] [PubMed]
82. Nicholson, J.K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions. Science 2012, 336, 1262-1267. [CrossRef] [PubMed]
83. Mutlu, E.; Keshavarzian, A.; Engen, P.; Forsyth, C.B.; Sikaroodi, M.; Gillevet, P. Intestinal dysbiosis: A possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol. Clin. Exp. Res. 2009, 33, 1836-1846. [CrossRef] [PubMed]
84. Mutlu, E.A.; Gillevet, P.M.; Rangwala, H.; Sikaroodi, M.; Naqvi, A.; Engen, P.A.; Kwasny, M.; Lau, C.K.; Keshavarzian, A. Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G966-G978. [CrossRef] [PubMed]
85. Yan, A.W.; Fouts, D.E.; Brandl, J.; Stärkel, P.; Torralba, M.; Schott, E.; Tsukamoto, H.; Nelson, K.E.; Brenner, D.A.; Schnabl, B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011, 53, 96-105. [CrossRef] [PubMed]
86. Bull-Otterson, L.; Feng, W.; Kirpich, I.; Wang, Y.; Qin, X.; Liu, Y.; Gobejishvili, L.; Joshi-Barve, S.; Ayvaz, T.; Petrosino, J.; et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS ONE 2013, 8, e53028. [CrossRef] [PubMed]
87. Chen, P.; Stärkel, P.; Turner, J.R.; Ho, S.B.; Schnabl, B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 2015, 61, 883-894.[CrossRef] [PubMed]
88. Shi, X.; Wei, X.; Yin, X.; Wang, Y.; Zhang, M.; Zhao, C.; Zhao, H.; McClain, C.J.; Feng, W.; Zhang, X. Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice. J. Proteome Res. 2015, 14, 1174-1182. [CrossRef] [PubMed]
89. Kirpich, I.A.; Solovieva, N.V.; Leikhter, S.N.; Shidakova, N.A.; Lebedeva, O.V.; Sidorov, P.I.; Bazhukova, T.A.; Soloviev, A.G.; Barve, S.S.; McClain, C.J.; et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study. Alcohol 2008, 42, 675-682. [CrossRef] [PubMed]
90. Hildebrandt, M.A.; Hoffmann, C.; Sherrill-Mix, S.A.; Keilbaugh, S.A.; Hamady, M.; Chen, Y.Y.; Knight, R.; Ahima, R.S.; Bushman, F.; Wu, G.D. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009. [CrossRef] [PubMed]
91. Turnbaugh, P.J.; Bäckhed, F.; Fulton, L.; Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3, 213-223. [CrossRef] [PubMed]
92. Turnbaugh, P.J.; Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Knight, R.; Gordon, J.I. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009. [CrossRef] [PubMed]
93. De Wit, N.; Derrien, M.; Bosch-Vermeulen, H.; Oosterink, E.; Keshtkar, S.; Duval, C.; de Vogel-van den Bosch, J.; Kleerebezem, M.; Müller, M.; van der Meer, R. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G589-G599. [CrossRef] [PubMed]
94. Wu, G.D.; Chen, J.; Hoffmann, C.; Bittinger, K.; Chen, Y.Y.; Keilbaugh, S.A.; Bewtra, M.; Knights, D.; Walters, W.A.; Knight, R.; et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334, 105-108. [CrossRef] [PubMed]
95. Duncan, S.H.; Lobley, G.E.; Holtrop, G.; Ince, J.; Johnstone, A.M.; Louis, P.; Flint, H.J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 2008, 32, 1720-1724. [CrossRef] [PubMed]
96. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559-563. [CrossRef] [PubMed]
97. Kirpich, I.; Petrosino, J.; Ajami, N.; Feng, W.; Wang, Y.; Liu, Y.; Beier, J.; Barve, S.; Yin, X.; Wei, X.; et al. Saturated and unsaturated dietary fats differentially modulate ethanol-induced changes in gut microbiome and metabolome in a mouse model of alcoholic liver disease. Am. J. Pathol. 2015, accepted.
98. Vanek, V.W.; Seidner, D.L.; Allen, P.; Bistrian, B.; Collier, S.; Gura, K.; Miles, J.M.; Valentine, C.J.; Kochevar, M.; Novel Nutrient Task Force, Intravenous Fat Emulsions Workgroup; et al. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr. Clin. Pract. 2012, 27, 150-192. [CrossRef] [PubMed]
99. Cresci, G.A.; Bush, K.; Nagy, L.E. Tributyrin supplementation protects mice from acute ethanol-induced gut injury. Alcohol. Clin. Exp. Res. 2014, 38, 1489-1501. [CrossRef] [PubMed]